Hikari Power portfolio

What changed this quarter

30 positions with a change (2 new, 1 added to, 18 trimmed, 9 sold). 12 are listed here: those of 0.5 points of the portfolio or more (up to 12).

• Berkshire Hathaway−34%fewer sharesReduced
  60.7% → 78.0%
• Johnson & Johnson−95%fewer sharesReduced
  4.7% → 0.5%
• Visa−80%fewer sharesReduced
  5.0% → 2.1%
• Exxon Mobil−79%fewer sharesReduced
  4.0% → 1.9%
• Phillips 66−78%fewer sharesReduced
  3.1% → 2.0%
• Alphabet−2.6 ppof portfolioReduced
  4.9% → 4.2%
• Linde−2.5 ppof portfolioSold out
  2.5% → —
• Roper Technologies−80%fewer sharesReduced
  2.4% → 1.0%
• Bank of New York Mellon−80%fewer sharesReduced
  2.0% → 0.8%
• Vanguard S&P 500 ETF−1.5 ppof portfolioSold out
  1.5% → —
• Moody's−74%fewer sharesReduced
  1.7% → 0.9%
• Nutrien−80%fewer sharesReduced
  1.1% → 0.5%

The figure on the right: for positions added to or trimmed, the change in the number of shares (%); for new and sold ones, the points of the portfolio moved (pp). Below, the portfolio weight before → after. Traded weight?: what it bought or sold, excluding price effects.

Top holdings

• Berkshire HathawayBRK/A · BRK/B78.9%Since at least Q1 2014 · 51 quartersDetails ▾
• AlphabetGOOG · GOOGL4.2%Since Q1 2023 · 15 quartersDetails ▾
• Vanguard Instl Index FundVGUS2.4%Since Q1 2026 · 3 quartersDetails ▾
• VisaV2.1%Since at least Q1 2014 · 51 quartersDetails ▾
• Phillips 66PSX2.0%Since Q2 2015 · 46 quartersDetails ▾
• Exxon MobilXOM1.9%Since Q2 2026 · 2 quartersDetails ▾
• DanaherDHR1.0%Since Q4 2015 · 44 quartersDetails ▾
• Vanguard Ultra Short Bond ET ETFVUSB1.0%Since Q1 2026 · 3 quartersDetails ▾
• Roper TechnologiesROP1.0%Since Q2 2016 · 42 quartersDetails ▾
• Moody'sMCO0.9%Since Q1 2023 · 15 quartersDetails ▾
• Bank of New York MellonBNY0.8%Since Q3 2018 · 33 quartersDetails ▾
• Johnson & JohnsonJNJ0.5%Since at least Q1 2014 · 51 quartersDetails ▾
• NutrienNTR0.5%Since Q4 2015 · 44 quartersDetails ▾
• WatersWAT0.4%Since Q2 2017 · 38 quartersDetails ▾
• ShellSHEL0.4%Since Q1 2022 · 19 quartersDetails ▾
• WabtecWAB0.4%Since Q1 2017 · 39 quartersDetails ▾
• Intuitive SurgicalISRG0.2%Since at least Q1 2014 · 51 quartersDetails ▾
• AmetekAME0.2%Since Q4 2020 · 24 quartersDetails ▾
• ZoetisZTS0.2%Since Q2 2026 · 2 quartersDetails ▾
• AmgenAMGN0.2%Since Q4 2016 · 40 quartersDetails ▾
• Agilent TechnologiesA0.1%Since Q2 2025 · 6 quartersDetails ▾
• Corvus PharmaceuticalsCRVS0.1%Since Q3 2018 · 33 quartersDetails ▾
• Veeva SystemsVEEV0.1%Since Q1 2020 · 27 quartersDetails ▾
• Novo Nordisk A/sNVO0.1%Since at least Q1 2014 · 51 quartersDetails ▾
• Mettler-Toledo InternationalMTD0.1%Since Q2 2025 · 6 quartersDetails ▾
• Lockheed MartinLMT0.1%Since Q1 2020 · 27 quartersDetails ▾
• TG TherapeuticsTGTX0.1%Since Q2 2026 · 2 quartersDetails ▾
• Vanguard Health Care ETFVHT0.1%Since Q2 2021 · 22 quartersDetails ▾
• BrookfieldBN0.1%Since Q4 2025 · 4 quartersDetails ▾
• Coca-ColaKOunder 0.1%Since Q3 2026 · 1 quarterDetails ▾
• Anavex Life SciencesAVXLunder 0.1%Since Q4 2018 · 32 quartersDetails ▾
• Ocular TherapeutixOCULunder 0.1%Since Q4 2021 · 20 quartersDetails ▾
• SabreSABRunder 0.1%Since Q3 2026 · 1 quarterDetails ▾
• Aldeyra TherapeuticsALDXunder 0.1%Since Q1 2017 · 39 quartersDetails ▾

“Since”: first quarter of the current run, unbroken until today. In the details, prices are the quarter-end prices of the quarters in which it added shares, per the 13F. The manager may have bought at any price within each quarter; the SEC only publishes the value at quarter end.